ABSTRACT
Objective Develop a bone shape measure that reflects the extent of cartilage loss and bone flattening in knee osteoarthritis (OA) and test it against estimates of disease severity.
Methods A fast region-based convolutional neural network was trained to crop the knee joints in sagittal dual-echo steady state MRI sequences obtained from the Osteoarthritis Initiative (OAI). Publicly available annotations of the cartilage and menisci were used as references to annotate the tibia and the femur in 61 knees. Another deep neural network (U-Net) was developed to learn these annotations. Model predictions were compared with radiologist-driven annotations on an independent test set (27 knees). The U-Net was applied to automatically extract the knee joint structures on the larger OAI dataset (9,434 knees). We defined subchondral bone length (SBL), a novel shape measure characterizing the extent of overlying cartilage and bone flattening, and examined its relationship with radiographic joint space narrowing (JSN), concurrent WOMAC pain and disability as well as subsequent partial or total knee replacement (KR). Odds ratios for each outcome were estimated using relative changes in SBL on the OAI dataset into quartiles.
Result Mean SBL values for knees with JSN were consistently different from knees without JSN. Greater changes of SBL from baseline were associated with greater pain and disability. For knees with medial or lateral JSN, the odds ratios between lowest and highest quartiles corresponding to SBL changes for future KR were 5.68 (95% CI:[3.90,8.27]) and 7.19 (95% CI:[3.71,13.95]), respectively.
Conclusion SBL quantified OA status based on JSN severity. It has promise as an imaging marker in predicting clinical and structural OA outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by a grant from the Karen Toffler Charitable trust, grants from the American Heart Association (17SDG33670323 & 20SFRN35460031), and grants from the Hariri Institute for Computing and Computational Science & Engineering and Digital Health Initiative at Boston University to VBK, NIH grants to TDC, DTF and VBK (U01-AG018820, R01-AR070139, R21-CA253498, R01-AG062109 and P30-AR072571) and support from the NIHR Manchester Biomedical Research Centre to DTF.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Python scripts are made available on GitHub (https://github.com/vkola-lab/ar2021).
